Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Holly Max

Physician Assistant, Medical Oklahoma City, OK Physician Assistant

NPI 1659926855 CMS profile 11310087

8325 Nw Expressway, Oklahoma City, OK 73162

Open in the dashboard

General payments

$5,660

231 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Holly Max of Oklahoma City, OK is reported in the CMS Open Payments database as having received $5,660 across 231 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $500 24
2024 General $817 42
2023 General $1,198 59
2022 General $3,145 106

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Holly Max
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Holly Max were reported at $500. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Holly Max Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $0 $156 $41–$563 $132
2022 $3,145 $185 $55–$649 $149
2023 $1,198 $199 $58–$717 $160
2024 $817 $206 $62–$740 $164
2025 $500 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $1,653 17 payments
  2. Bayer HealthCare Pharmaceuticals Inc. $539 28 payments
  3. AstraZeneca Pharmaceuticals LP $455 25 payments
  4. Janssen Pharmaceuticals, Inc $392 23 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $320 15 payments
  6. Kowa Pharmaceuticals America, Inc. $266 24 payments
  7. Lilly USA, LLC $257 16 payments
  8. Novo Nordisk Inc $197 10 payments
  9. Amgen Inc. $183 9 payments
  10. Esperion Therapeutics, Inc. $179 10 payments
  11. Other $1,220 54 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $4,627 223 payments
  2. Travel and Lodging $1,018 7 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16 1 payment
Products named General payments · program years 2022–2025
  1. Micra $682 3 payments
  2. Kerendia $539 28 payments
  3. XARELTO $392 23 payments
  4. FARXIGA $294 15 payments
  5. Livalo $266 24 payments
  6. JARDIANCE $192 9 payments
  7. NEXLETOL $179 10 payments
  8. BRILINTA $173 7 payments
  9. Seglentis $157 15 payments
  10. VERQUVO $155 7 payments
  11. Other $2,321 114 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

231 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record